Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Polycythemia Vera 3Myeloproliferative Disorders 3Ovarian Neoplasms 2Thymic aplasia 1Prostatic Neoplasms 1Nephritis 1Neoplasms 1Neoplasm Metastasis 1Immunologic Deficiency Syndromes 1Digestive System Diseases 1Colorectal Neoplasms 1Colorectal Adenocarcinoma 1Autoimmune Diseases 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 65Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 30Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Rituximab 22Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Phlebotomy × Clear all
NCT03884400 2022-11-14

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

iSpecimen Inc

Withdrawn

Autoimmune Diseases, Digestive System Diseases, Neoplasms, Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡